We are live on ! Find out more
CRB

Chad R. Baker Portfolio holdings

AUM $620M Turnover 12.28%
1-Year Est. Return 42.67%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.08%
10 Year Est. Return
+563.15%
AUM
$479M
AUM Growth
+$9.48M
Cap. Flow
-$10.4M
Cap. Flow %
-2.18%
Top 10 Hldgs %
47.36%
Holding
54
New
1
Increased
8
Reduced
11
Closed
3
Avg Time Held
5.8 years
Top 10 Avg Time Held
2.9 years
Top 20 Avg Time Held
4.6 years

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.23M
2
VLTO icon
Veralto
VLTO
+$1.9M
3
ALC icon
Alcon
ALC
+$1.73M
4
MKC icon
McCormick & Company Non-Voting
MKC
+$371K
5
APTV icon
Aptiv
APTV
+$356K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$7.71M
2
NKE icon
Nike
NKE
+$7.44M
3
AAPL icon
Apple
AAPL
+$1.88M
4
SJM icon
J.M. Smucker
SJM
+$214K
5
PG icon
Procter & Gamble
PG
+$123K

Sector Composition

Rank Sector Weight
1 Technology 34.49%
2 Industrials 19.13%
3 Healthcare 16.54%
4 Consumer Discretionary 10.76%
5 Communication Services 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
WMT icon
26
Walmart Inc
WMT
$943B
$6.98M 1.46%
103,020
– –
2015 Q4
34 quarters
TJX icon
27
TJX Companies
TJX
$162B
$6.86M 1.43%
62,340
– –
2022 Q4
6 quarters
SYK icon
28
Stryker
SYK
$113B
$6.51M 1.36%
19,145
– –
2017 Q1
29 quarters
LOW icon
29
Lowe's Companies
LOW
$111B
$6.19M 1.29%
28,100
– –
2015 Q4
34 quarters
HD icon
30
Home Depot
HD
$309B
$6.07M 1.27%
17,635
– –
2015 Q4
34 quarters
ALC icon
31
Alcon
ALC
$32B
$5.44M 1.13%
61,025
+20,230
+50% +$1.73M
2023 Q4
2 quarters
CRSP icon
32
CRISPR Therapeutics
CRSP
$4.76B
$5.32M 1.11%
98,520
– –
2023 Q3
3 quarters
ADBE icon
33
Adobe
ADBE
$95.4B
$5M 1.04%
9,000
– –
2015 Q4
34 quarters
CL icon
34
Colgate-Palmolive
CL
$75B
$4.97M 1.04%
51,200
– –
2015 Q4
34 quarters
ZTS icon
35
Zoetis
ZTS
$32.8B
$4.3M 0.9%
24,818
– –
2015 Q4
34 quarters
GOOG icon
36
Alphabet (Google) Class C
GOOG
$4.12T
$4.05M 0.85%
22,100
– –
2015 Q4
34 quarters
RTX icon
37
RTX Corp
RTX
$261B
$3.85M 0.8%
38,348
– –
2020 Q2
16 quarters
WIRE icon
38
DELISTED
Encore Wire Corp
WIRE
$3.77M 0.79%
13,000
– –
2015 Q4
34 quarters
CSX icon
39
CSX Corp
CSX
$90.2B
$3.41M 0.71%
102,000
– –
2015 Q4
34 quarters
MRK icon
40
Merck
MRK
$360B
$2.69M 0.56%
21,700
– –
2015 Q4
34 quarters
VRTX icon
41
Vertex Pharmaceuticals
VRTX
$127B
$2.41M 0.5%
+5,145
New +$2.23M
2024 Q2
0 quarters
CI icon
42
Cigna
CI
$79.9B
$1.93M 0.4%
5,841
– –
2018 Q4
22 quarters
XOM icon
43
ExxonMobil
XOM
$736B
$1.89M 0.39%
16,400
– –
2015 Q4
34 quarters
CNI icon
44
Canadian National Railway
CNI
$73.6B
$1.56M 0.33%
13,220
-55
-0.4% -$6.89K
2015 Q4
34 quarters
NVDA icon
45
NVIDIA
NVDA
$5.17T
$1.33M 0.28%
10,750
-200
-2% -$20.2K
2023 Q1
5 quarters
FTV icon
46
Fortive
FTV
$17.5B
$1.11M 0.23%
19,905
– –
2016 Q3
31 quarters
APTV icon
47
Aptiv
APTV
$9.31B
$1.05M 0.22%
14,845
+4,625
+45% +$356K
2023 Q4
2 quarters
NVO icon
48
Novo Nordisk
NVO
$171B
$768K 0.16%
5,380
– –
2023 Q1
5 quarters
MKC icon
49
McCormick & Company Non-Voting
MKC
$12.5B
$760K 0.16%
10,715
+5,095
+91% +$371K
2024 Q1
1 quarter
BDX icon
50
Becton Dickinson
BDX
$52.2B
$706K 0.15%
3,020
+1,070
+55% +$252K
2023 Q2
4 quarters
1
2
3

Similar funds

PLU
Performa Ltd (US) Charleston, South Carolina $620M AUM 19.43% 1-Year Est. Return
RR
Robotti Robert $620M AUM 55.18% 1-Year Est. Return
TAIM
Te Ahumairangi Investment Management Wellington, New Zealand $620M AUM 14.43% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
MAC
Mason & Associates (California) Los Angeles, California $619M AUM 29.44% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $621M AUM 15.59% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $621M AUM 34.06% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $621M AUM 14.19% 1-Year Est. Return

Chad R. Baker's Q2 2024 Portfolio in Review

As of Q2 2024, Chad R. Baker held 54 positions worth $479M, up 2% from $470M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Chad R. Baker's Q2 2024 filing shows 1 new, 8 increased, 11 reduced and 3 closed positions. Its largest new stake was Vertex Pharmaceuticals: 5,145 shares worth $2.41M. The largest sale was CVS Health, an estimated $7.71M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Industrials and Healthcare.

  • Chad R. Baker's largest Q2 2024 buy was Vertex Pharmaceuticals: 5,145 shares worth $2.41M.
  • Chad R. Baker added most to Veralto in Q2 2024, an estimated $1.9M increase.
  • Chad R. Baker's biggest Q2 2024 reduction was Apple, cutting an estimated $1.88M.
  • Chad R. Baker fully exited CVS Health in Q2 2024, selling an estimated $7.71M.
  • Chad R. Baker's ten largest holdings make up 47% of its $479M portfolio in Q2 2024.
  • Chad R. Baker opened 1 new position and closed 3 in Q2 2024.
  • Chad R. Baker's portfolio value rose 2% quarter-over-quarter to $479M.

Based on Chad R. Baker's 13F filing for Q2 2024, filed 22 Jul 2024.